DIAGNOSTICS OF CHRONIC HEART INSUFFICIENCY IN PATIENTS WITH METABOLIC SYNDROME BY SODIURETIC PEPTIDE LEVEL

Abstract

Symptoms and clinical signs of chronic heart failure (CHF) are very difficult to identify and, just as important, correctly interpreted in obese patients and in patients with metabolic syndrome ( MS ) . In this case, for the verification and differentiation of breathing in CHF or obesity , it is necessary to quantify the level of cerebral natriuretic peptide (BNP) in the blood serum . For the diagnosis of CHF, not only echocardiography with the determination of the ejection fraction ( EF ) is shown , but also the quantitative determination of the level of BNP in the blood serum .The components of metabolic syndrome (MS): arterial gipert onium ( AG ) , abdominal obesity (AO), insulin resistance (IR), type 2 diabetes are major risk factors for the development of chronic heart failure with preserved ejection fraction (EF) . Obesity is one of the most common chronic diseases in the world and is socially significant. For the diagnosis and treatment of chronic heart failure in the early stages of the disease, it is important to timely assess the features of CHF in patients with MS. It is necessary to develop recommendations for the management of this group of patients on the basis of a follow-up program.